CYCN · Categories · Form 4

CYCN - SEC Form 4 insider transactions

Cyclerion Therapeutics Inc. (CYCN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CYCN

• 258d
  SEC Form 4 filed by Chief Financial Officer Chicko Rhonda M.

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 395d
  Director Hecht Peter M was granted 181,818 shares, increasing direct ownership by 48% to 559,203 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 395d
  Director Higgins Michael J was granted 9,090 shares, increasing direct ownership by 42% to 30,740 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 517d
  Large owner Slate Path Capital Lp sold $555,108 worth of shares (357,880 units at $1.55) (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 627d
  SEC Form 4 filed by Officer Graul Regina Margaret

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 821d
  Hecht Peter M was granted 15,000 shares, increasing direct ownership by 4% to 377,385 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 821d
  Graul Regina Margaret was granted 50,000 shares, increasing direct ownership by 99% to 100,303 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 874d
  Mcguire Terrance was granted 5,000 shares, increasing direct ownership by 906% to 5,552 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 874d
  Hecht Peter M was granted 35,000 shares, increasing direct ownership by 11% to 362,385 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 874d
  Desouza Errol B was granted 50,000 shares (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 874d
  Hyman Steven was granted 20,000 shares (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 989d
  SEC Form 4: Mcguire Terrance sold $27 worth of shares (8 units at $3.40)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1070d
  SEC Form 4 filed by Hecht Peter M

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1369d
  SEC Form 4 filed by Hyman Steven (Amendment)

  4/A - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1370d
  SEC Form 4 filed by Hyman Steven

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1410d
  SEC Form 4 filed by Mendelsohn Michael

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1410d
  SEC Form 4 filed by Mcguire Terrance

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1410d
  SEC Form 4 filed by Conrades George H

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1410d
  SEC Form 4 filed by Lovell Stephanie

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1410d
  SEC Form 4 filed by Fanucci Marsha

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1410d
  SEC Form 4 filed by Isacson Ole

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1410d
  SEC Form 4 filed by Desouza Errol B

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1553d
  SEC Form 4 filed by Busch Andreas

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1553d
  SEC Form 4 filed by Gjino Anjeza

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1553d
  SEC Form 4 filed by Hecht Peter M

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1553d
  SEC Form 4 filed by Gault Cheryl

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1598d
  SEC Form 4 filed by Busch Andreas

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1598d
  SEC Form 4 filed by Gjino Anjeza

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1598d
  SEC Form 4 filed by Gault Cheryl

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1763d
  SEC Form 4 filed by Lovell Stephanie

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1763d
  SEC Form 4 filed by Fanucci Marsha

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1763d
  SEC Form 4 filed by Isacson Ole

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1763d
  SEC Form 4 filed by Churchwell Kevin

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1763d
  SEC Form 4 filed by Mendelsohn Michael

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1763d
  SEC Form 4 filed by CONRADES GEORGE H

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1763d
  SEC Form 4 filed by DESOUZA ERROL B

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1763d
  SEC Form 4 filed by MCGUIRE TERRANCE

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1784d
  SEC Form 4: MCGUIRE TERRANCE bought $299,997 worth of Common Stock (96,153 units at $3.12)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1784d
  SEC Form 4 filed by Cyclerion Therapeutics, Inc.

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1784d
  SEC Form 4: Slate Path Capital LP bought $2,999,999 worth of Common Stock (961,538 units at $3.12)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1812d
  SEC Form 4: Hecht Peter M bought $733,860 worth of Common Stock (302,000 units at $2.43), increasing direct ownership by 33% to 1,224,528 units

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1816d
  SEC Form 4: Hecht Peter M bought $1,693,943 worth of Common Stock (698,001 units at $2.43), increasing direct ownership by 311% to 922,528 units

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1882d
  SEC Form 4: Anjeza Gjino sold $7,296 worth of Common Stock (1,824 units at $4.00), decreasing ownership by 5% to 31,599 units

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1882d
  SEC Form 4: I Christopher Wright sold $10,522 worth of Common Stock (2,637 units at $3.99), decreasing ownership by 6% to 42,728 units

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)

Other CYCN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends